Cancer: T cells are the front line of our body’s defenses, and their mission is to search and destroy anything that causes illness or infection. With cancer, the immune system often fails to deploy T cells right away or at all. CAR T-Cell Therapy is an extraordinary and innovative cancer treatment that engineers a patient’s own cells to hunt and attack cancer cells by producing chimeric antigen receptors (or CARs) that adhere to tumors and destroy them. With a number of newly FDA-approved products on the market, this personalized, next-generation treatment is a powerful tool for treating advanced forms of blood cancer, bringing newfound hope to patients and families while changing the treatment paradigm. Join us for a conversation with a team of experts from industry leader Bristol Myers Squibb.

Presented in partnership with RI Bio.

May 26, 2022